Method
Level · gp.fundamentals.capex_revenue_ratio
Raw value 2.83% · OPTIONAL
· Surgical & Medical Instruments & Apparatus
RESEARCH SNAPSHOTFEMASYS INC's latest supported as-filed period reports revenue of $331,827, 18.9% below the comparable as-filed period. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Level · gp.fundamentals.capex_revenue_ratio
Raw value 2.83% · OPTIONAL
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value -1186.07% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value -18.92% · CORE
Level · gp.fundamentals.inventory_revenue_ratio
Raw value 1865.81% · OPTIONAL
Level · gp.fundamentals.operating_margin
Raw value -1526.66% · CORE
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
Raw value 586.71% · OPTIONAL
Level · gp.fundamentals.sbc_revenue_ratio
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Cash & equivalents changed -55.1% from the comparable as-filed period.
Inventory changed +18.3% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Net income changed +2.5% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
FEMY · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001140361-26-033157SEC ↗8-KAug 14, 2026Period Aug 14, 20260001140361-26-033145SEC ↗4Aug 11, 2026Period Jun 24, 20260001140361-26-032349SEC ↗4Aug 11, 2026Period Jun 24, 20260001140361-26-032347SEC ↗4Aug 11, 2026Period Jun 24, 20260001140361-26-032345SEC ↗4Aug 11, 2026Period Jun 24, 20260001140361-26-032339SEC ↗4Aug 11, 2026Period Aug 7, 20260001140361-26-032336SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Jun 24, 2026Filed Aug 11, 2026 | Eichenbaum Kenneth D.Director | Grant Or AwardDirect | 880 | $0 | $0 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Raw value 63.53% · OPTIONAL
Operating income changed -31.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating margin changed -58557 basis points from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Research & development changed +37.6% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Revenue changed -18.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001140361-26-032332